Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study.

Wadbo, Monika LU ; Löfdahl, Claes-Göran LU ; Larsson, K ; Skoogh, B E ; Tornling, G ; Arweström, E ; Bengtsson, T and Ström, K (2002) In European Respiratory Journal 20(5). p.1138-1146
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Cholinergic Antagonists: adverse effects, Carbon Dioxide: blood, Chronic Obstructive: physiopathology, Quality of Life, Vital Capacity, Walking, Chronic Obstructive: drug therapy, Pulmonary Disease, Adrenergic beta-Agonists: adverse effects, Adrenergic beta-Agonists: therapeutic use, Adult, Aged, Bronchodilator Agents: adverse effects, Bronchodilator Agents: therapeutic use, Cholinergic Antagonists: therapeutic use, Comparative Study, Double-Blind Method, Dyspnea: etiology, Ethanolamines: adverse effects, Ethanolamines: therapeutic use, Female, Forced Expiratory Volume, Human, Ipratropium: adverse effects, Ipratropium: therapeutic use, Male, Middle Age, Oxygen: blood, Physical Endurance
in
European Respiratory Journal
volume
20
issue
5
pages
1138 - 1146
publisher
European Respiratory Society
external identifiers
  • wos:000179176500011
  • pmid:12449166
  • scopus:0036849465
ISSN
1399-3003
DOI
10.1183/09031936.02.00301702
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Respiratory Medicine and Allergology (013230111), Lung medicine (Malmö) (ceased) (LUR000013), Division of Clinical Chemistry and Pharmacology (013250300)
id
1a078872-a900-4929-93b8-fef3cd93d306 (old id 114693)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12449166&dopt=Abstract
date added to LUP
2016-04-01 12:11:05
date last changed
2022-01-26 23:58:41
@article{1a078872-a900-4929-93b8-fef3cd93d306,
  author       = {{Wadbo, Monika and Löfdahl, Claes-Göran and Larsson, K and Skoogh, B E and Tornling, G and Arweström, E and Bengtsson, T and Ström, K}},
  issn         = {{1399-3003}},
  keywords     = {{Cholinergic Antagonists: adverse effects; Carbon Dioxide: blood; Chronic Obstructive: physiopathology; Quality of Life; Vital Capacity; Walking; Chronic Obstructive: drug therapy; Pulmonary Disease; Adrenergic beta-Agonists: adverse effects; Adrenergic beta-Agonists: therapeutic use; Adult; Aged; Bronchodilator Agents: adverse effects; Bronchodilator Agents: therapeutic use; Cholinergic Antagonists: therapeutic use; Comparative Study; Double-Blind Method; Dyspnea: etiology; Ethanolamines: adverse effects; Ethanolamines: therapeutic use; Female; Forced Expiratory Volume; Human; Ipratropium: adverse effects; Ipratropium: therapeutic use; Male; Middle Age; Oxygen: blood; Physical Endurance}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{1138--1146}},
  publisher    = {{European Respiratory Society}},
  series       = {{European Respiratory Journal}},
  title        = {{Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study.}},
  url          = {{http://dx.doi.org/10.1183/09031936.02.00301702}},
  doi          = {{10.1183/09031936.02.00301702}},
  volume       = {{20}},
  year         = {{2002}},
}